Literature DB >> 12187079

Novel aspects of transforming growth factor-Beta in diabetic kidney disease.

Ken-ichi Tsuchida1, Brian Cronin, Kumar Sharma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12187079     DOI： 10.1159/000064486

Source DB:  PubMed          Journal:  Nephron        ISSN： 1660-8151            Impact factor:   2.847


× No keyword cloud information.
  7 in total

1.  Reactive oxygen species production via NADPH oxidase mediates TGF-beta-induced cytoskeletal alterations in endothelial cells.

Authors:  Taishan Hu; Satish P Ramachandrarao; Senthuran Siva; Cathryn Valancius; Yanqing Zhu; Kalyankar Mahadev; Irene Toh; Barry J Goldstein; Marilyn Woolkalis; Kumar Sharma
Journal:  Am J Physiol Renal Physiol       Date:  2005-10

Review 2.  New pharmacological treatments for improving renal outcomes in diabetes.

Authors:  Anne-Emilie Declèves; Kumar Sharma
Journal:  Nat Rev Nephrol       Date:  2010-05-04       Impact factor: 28.314

3.  Thrombospondin 1 and Its Diverse Roles as a Regulator of Extracellular Matrix in Fibrotic Disease.

Authors:  Joanne E Murphy-Ullrich
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

4.  Blockade of TSP1-dependent TGF-β activity reduces renal injury and proteinuria in a murine model of diabetic nephropathy.

Authors:  Ailing Lu; Mi Miao; Trenton R Schoeb; Anupam Agarwal; Joanne E Murphy-Ullrich
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

Review 5.  Growth factors and the development of diabetic nephropathy.

Authors:  Gunter Wolf
Journal:  Curr Diab Rep       Date:  2003-12       Impact factor: 5.430

Review 6.  Immune responses in diabetic nephropathy: Pathogenic mechanisms and therapeutic target.

Authors:  Jiahao Chen; Qinhui Liu; Jinhan He; Yanping Li
Journal:  Front Immunol       Date:  2022-08-15       Impact factor: 8.786

Review 7.  Role of Neuropilin-1 in Diabetic Nephropathy.

Authors:  Tzvetanka Bondeva; Gunter Wolf
Journal:  J Clin Med       Date:  2015-06-17       Impact factor: 4.241
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.